GlassScriptPhysician profile
Megan Harrison
NPI 1164504890
$1,134.21
in general payments reported to CMS, 2019-2025
13 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.06 · 2022: $60.63 · 2023: $164 · 2024: $656 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $685.72 | 2024-2025 | Daxxify |
| Astellas Pharma US INC | $77.93 | 2023 | Veozah |
| Novo Nordisk INC | $74.12 | 2023-2025 | Ozempic |
| Galderma Laboratories, L.P. | $72.79 | 2023-2024 | |
| Lilly USA, LLC | $45.68 | 2021-2024 | Zepbound |
| Genentech USA, INC. | $45.65 | 2021 | |
| Merck Sharp & Dohme LLC | $35.14 | 2022 | |
| Phathom Pharmaceuticals, INC. | $20.72 | 2024 | Voquezna |
| Kedrion Biopharma, INC. | $19.18 | 2024 | Albuked, Rhogam Ultra-Filtered Plus, Gammaked |
| Morphosys, US INC. | $16.30 | 2023 | Monjuvi |
| Aveo Pharmaceuticals, INC. | $15.49 | 2025 | |
| Merz North America, INC. | $13.49 | 2022 | |
| Allergan, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.